PAVmed (PAVM) Non Operating Interest Expenses (2017 - 2026)

PAVmed has reported Non Operating Interest Expenses for 10 years, with the latest figure at $2000.0 in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 50.0% year-over-year to $2000.0 in Q2 2026; TTM through Jun 2026 was $9000.0, a 81.25% decrease from a year earlier, with the FY2025 full-year figure at $21000.0, down 53.33% from the prior year.
• Non Operating Interest Expenses was $2000.0 for Q2 2026 at PAVmed, up from -$5000.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $525000.0 in Q3 2022, with the low at -$5000.0 in Q4 2025.
• Average Non Operating Interest Expenses over 5 years is $129200.0, with a median of $19000.0 recorded in 2023.
• The largest YoY upside for Non Operating Interest Expenses was 62.5% in 2025 against a maximum downside of 171.43% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $232000.0 in 2022, then sank by 91.81% to $19000.0 in 2023, then sank by 63.16% to $7000.0 in 2024, then plunged by 171.43% to -$5000.0 in 2025, then soared by 140.0% to $2000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $2000.0 (Q2 2026), -$5000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.